Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $3.17 Analyst target: $6.25 Upside: 97.16%
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.